Fig. 3From: Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis studyEstimates of hospitalizations, ICU admissions and deaths prevented from cases prevented by mass testingBack to article page